Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study

Hepatology

Volumn 26, Issue 3, 1997, Pages 776-779

  Serfaty, Lawrence ^a   Chazouillères, Olivier ^a   Poujol Robert, Armelle ^a   Morand Joubert, Laurence ^a   Dubois, Catherine ^a   Chrétien, Yves ^b   Poupon, Renée L ^b   Petit, Jean Claude ^a   Poupon, Raoul ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; HEPATITIS B CORE ANTIGEN;

ADULT; AGED; ALCOHOLISM; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0030842725     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260334     Document Type: Article

References (35)

1. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. HEPATOLOGY 1991;14:969-74.
2. Hopf U, Khther D, Stemerowicz R, Lobeck H, Lhdtke-Handjery A, Walter E, Blum HE, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990;10:69-76.
3. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993;88:240-243.
4. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C, and the Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-168.
5. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, McIntyre N, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. HEPATOLOGY 1994;19:13-18.
6. Pozzato G, Kaneko S, Morreti M, Croce L, Franzin F, Unoura M, Bereich L, et al. Different genotypes of hepatitis C virus are associated with different severity of liver disease. J Med Virol 1994;43:291-296.
7. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. HEPATOLOGY 1995;21: 285-290.
8. Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T, Takayanagi M. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994;39:234-239.
9. Mita E, Hayashi N, Kanazawa Y, Hagiwara H, Ueda K, Kasahara, Fusamoto H, et al. Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease. J Hepatol 1994;21:468-473.
10. Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, Zanuso F, et al. Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology 1996; 110:178-183.
11. Silini E, Bottelli R, Asti M, Bruno S, Candusso ME, Brambilla S, Bono F, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 1996;111:199-205.
12. Pol S, Thiers V, Nousbaum JB, Legendre C, Berthelot P, Kreis H, Brechot C. The changing prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995; 108:581-583.
13. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;171:1607-1610.
14. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-1102.
15. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. HEPATOLOGY 1994;19:1321-1324.
16. Poupon RE, Schellenberg F, Nalpas B, Weill J. Assessement of the transferrin index in screening heavy drinkers from a general practice. Alcohol Clin Exp Res 1989;13:549-551.
17. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
18. Shindo M, Arai K, Sokawa Y, Okuno T. The virological and histological states of anti-hepatitis C virus positive subjects with normal liver biochemical values. HEPATOLOGY 1995;22:418-425.
19. Serfaty L, Chazouillères O, Pawlotsky JM, Andreani T, Pellet C, Poupon R. Level of viremia, genotype, histological features and effect of interferon (IFN) therapy in hepatitis C virus (HCV) carriers with persistently normal ALT activity [Abstract]. HEPATOLOGY 1994;20:165A.
20. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynes M, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-1096.
21. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996,334:815-820.
22. Belli LS, Silini E, Alberti A, Bellati G, Gelosa F, Asti L, Rondinara L, et al. HCV genotypes, posttransplant hepatitis (PTH) and HCV recurrence after liver transplantation [Abstract]. HEPATOLOGY 1994;20:131A.
23. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JYN, Simmonds P, Roberts JP, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. HEPATOLOGY 1996;24:1041-1046.
24. Gretch DR, Bacchi CE, Corey L, Rosa C, Lesniewski RR, Kowdley K, Gown A, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. HEPATOLOGY 1995;22:1-9.
25. Chazouillères O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-999.
26. Hodges JR, Millward-Sadler GH, Barbatis C, Wright R. Heterozygous MZ aj-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenetic cirrhosis. N Engl J Med 1981;304:557-560.
27. 1-antitrypsin deficiency in adults with chronic liver disease. Scand J Gastroenterol 1990;25:788-792.
28. Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W. Prevalence of hepatocellular carcinoma in alpha-1-antitrypsin deficiency. J Hepatol 1994;21:1006-1011.
29. 1-antitrypsin (PI) polymorphism in France, with special regard to the PI*Z allele. Hum Hered 1991;41:340-346.
30. Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon R. Prevalence, severity and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening test. HEPATOLOGY 1995;20:725-729.
31. Zignego AL, Foschi M, Laffi G, Monti M, Careccia G, Romanelli RG, De Majo E, et al. "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. HEPATOLOGY 1994;19:577-582.
32. Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, Castillo R, et al. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. HEPATOLOGY 1990;12: 1295-1299.
33. Fong TL, Kanel GC, Conrad A, Valinluck B, Charboneau F, Adkins RH. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. HEPATOLOGY 1994;19:554-557.
34. Mendenhall CL, Seef L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. HEPATOLOGY 1991;14:581-589.
35. Cromie SL, Jenkins PJ, Bowden S, Dudley FJ. Chronic hepatitis C: effect of alcohol on hepatic activity and viral titer. J Hepatol 1996;25:821-826.